Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation. Founded by Mohamed Naguib in 2015, Neuro Therapia is backed by investors that include Cleveland Clinic, Dolby Family Ventures, Alzheimer’s Drug Discovery Foundation, and Brain Trust Accelerator Fund and is headquartered in Ohio.